2,266
Views
39
CrossRef citations to date
0
Altmetric
Research Article

A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma

, , , , &
Pages 10-20 | Received 05 Feb 2014, Accepted 09 Mar 2014, Published online: 15 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shumei Zhang, Caixia Lu, Xiaoli Zhang, Junsheng Li & Hong Jiang. (2016) Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system. Drug Delivery 23:5, pages 1838-1845.
Read now
Xiang Yu, Lina Du, Lifei Zhu, Xiaoyan Liu, Baolei Zhang, Guiying Fu & Yiguang Jin. (2016) Melanoma therapy with transdermal mitoxantrone cubic phases. Drug Delivery 23:5, pages 1565-1570.
Read now

Articles from other publishers (37)

Anbazhagan Thirumalai, Koyeli Girigoswami, Pragya Pallavi, Karthick Harini, Pemula Gowtham & Agnishwar Girigoswami. (2023) Cancer therapy with iRGD as a tumor-penetrating peptide. Bulletin du Cancer 110:12, pages 1288-1300.
Crossref
Xiaohui Wang, Hong Zhang, Xiaohui Chen, Chunrong Wu, Ke Ding, Guiyin Sun, Yang Luo & Debing Xiang. (2023) Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery. Acta Biomaterialia 166, pages 42-68.
Crossref
Jing Qian, Sheng Zhou, Peng Lin, Jin Lei, Shiqi Zheng, Wenmang Xu, Yuanyuan Wang, Ziran Gao & Julun Yang. (2023) Recent advances in the tumor‐penetrating peptide internalizing RGD for cancer treatment and diagnosis. Drug Development Research 84:4, pages 654-670.
Crossref
Meichen Zhang, Yangyang Ge, Shilin Xu, Xiaocui Fang, Jie Meng, Lanlan Yu, Chenxuan Wang, Jian Liu, Tao Wen, Yanlian Yang, Chen Wang & Haiyan Xu. (2022) Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia. Pharmacological Research 185, pages 106503.
Crossref
Muhammad Usman Munir. (2022) Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue. Cancers 14:12, pages 2904.
Crossref
Chaohui Luo, Minglu Zhou, Cheng Chen, Shujie Li, Qiuyi Li, Yuan Huang & Zhou Zhou. (2022) A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages. Nanoscale 14:12, pages 4573-4587.
Crossref
Andrey S. Drozdov, Petr I. Nikitin & Julian M. Rozenberg. (2021) Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen. International Journal of Molecular Sciences 22:23, pages 13011.
Crossref
Layla Al-mansoori, Philip Elsinga & Sayed K. Goda. (2021) Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomedicine & Pharmacotherapy 144, pages 112260.
Crossref
Jie Zhou, Shengnan Ma, Yuxin Zhang, Yiyan He, Hongli Mao, Jun Yang, Hu Zhang, Kui Luo, Qiyong Gong & Zhongwei Gu. (2021) Bacterium-mimicking sequentially targeted therapeutic nanocomplexes based on O-carboxymethyl chitosan and their cooperative therapy by dual-modality light manipulation. Carbohydrate Polymers 264, pages 118030.
Crossref
Mengting Liu, Wenjuan Ma, Dan Zhao, Jiajie Li, Qirong Li, Yuhao Liu, Liying Hao & Yunfeng Lin. (2021) Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces 13:22, pages 25825-25835.
Crossref
Farshad Mirzavi, Mehdi Barati, Anvar Soleimani, Roghayyeh Vakili-Ghartavol, Mahmoud Reza Jaafari & Mohammad Soukhtanloo. (2021) A review on liposome-based therapeutic approaches against malignant melanoma. International Journal of Pharmaceutics 599, pages 120413.
Crossref
Yuchen Fan, Maria Marioli & Kelly Zhang. (2021) Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. Journal of Pharmaceutical and Biomedical Analysis 192, pages 113642.
Crossref
Sujin Kang, Sooyeun Lee & Soyeun Park. (2020) iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers 12:9, pages 1906.
Crossref
Dianlong Jia, Yujiao Yang, Fengjiao Yuan, Qing Fan, Feifei Wang, Yujiao Huang, Hao Song, Ping Hu, Rui Wang, Guangyong Li, Renmin Liu & Jun Li. (2020) Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models. International Journal of Pharmaceutics 586, pages 119541.
Crossref
Wen Xiao, Weiyi Zhang, Hai Huang, Yafei Xie, Yi Zhang, Xia Guo, Chaohui Jin, Xuelian Liao, Shaohua Yao, Guo Chen & Xiangrong Song. (2019) Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes. Molecular Pharmaceutics 17:1, pages 229-238.
Crossref
Sota Kimura, Tatsuya Oda, Osamu Shimomura, Tsuyoshi Enomoto, Shinji Hashimoto, Yukihito Kuroda, Yang Yu, Ko Kurimori, Tomoaki Furuta, Yoshihiro Miyazaki & Hiroaki Tateno. (2020) Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. European Surgical Research 61:4-5, pages 113-122.
Crossref
Jianxun Ding, Jinjin Chen, Liqian Gao, Zhongyu Jiang, Yu Zhang, Mingqiang Li, Qicai Xiao, Su Seong Lee & Xuesi Chen. (2019) Engineered nanomedicines with enhanced tumor penetration. Nano Today 29, pages 100800.
Crossref
Pauline Resnier, Elise Lepeltier, Anthea Lucrezia Emina, Natacha Galopin, Jérôme Bejaud, Stephanie David, Caroline Ballet, Thierry Benvegnu, Frédéric Pecorari, Igor Chourpa, Jean-Pierre Benoit & Catherine Passirani. (2019) Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements . RSC Advances 9:47, pages 27264-27278.
Crossref
Yu Sheng, Zhen Wang, Gella Maelys Ngandeu Neubi, Hao Cheng, Chenshuang Zhang, Huaqing Zhang, Ruoning Wang, Jianping Zhou & Yang Ding. (2019) Lipoprotein-inspired penetrating nanoparticles for deep tumor-targeted shuttling of indocyanine green and enhanced photo-theranostics. Biomaterials Science 7:8, pages 3425-3437.
Crossref
Houdong Zuo. (2019) iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers. Journal of Oncology 2019, pages 1-15.
Crossref
Shuaishuai Feng, Zi-Xin Wu, Ziyan Zhao, Jinhu Liu, Kaoxiang Sun, Chuanyou Guo, Hongbo Wang & Zimei Wu. (2019) Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma. ACS Applied Materials & Interfaces 11:7, pages 7357-7368.
Crossref
Yandan Yao, Phei Er Saw, Yan Nie, Ping-Pui Wong, Linjia Jiang, Xiaojing Ye, Jun Chen, Tao Ding, Liang Xu, Herui Yao, Hai Hu & Xiaoding Xu. (2019) Multifunctional sharp pH-responsive nanoparticles for targeted drug delivery and effective breast cancer therapy. Journal of Materials Chemistry B 7:4, pages 576-585.
Crossref
Ruirui Qiao, Kun Wang & Jian Zhong. 2018. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Peptide Applications in Biomedicine, Biotechnology and Bioengineering 371 386 .
Debadyuti Ghosh, Xiujuan Peng, Jasmim Leal & Rashmi P. Mohanty. (2017) Peptides as drug delivery vehicles across biological barriers. Journal of Pharmaceutical Investigation 48:1, pages 89-111.
Crossref
Li Zhang, Yanfeng Xing, Qi Gao, Xuejun Sun, Di Zhang & Gang Cao. (2017) Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells. Biomedicine & Pharmacotherapy 93, pages 1136-1143.
Crossref
Erkki Ruoslahti. (2017) Tumor penetrating peptides for improved drug delivery. Advanced Drug Delivery Reviews 110-111, pages 3-12.
Crossref
Maurizio Roveri, Michele Bernasconi, Jean-Christophe Leroux & Paola Luciani. (2017) Peptides for tumor-specific drug targeting: state of the art and beyond. Journal of Materials Chemistry B 5:23, pages 4348-4364.
Crossref
Xiangsheng Liu, Jinhong Jiang, Ying Ji, Jianqin Lu, Ryan Chan & Huan Meng. (2017) Targeted drug delivery using iRGD peptide for solid cancer treatment. Molecular Systems Design & Engineering 2:4, pages 370-379.
Crossref
Ankit Jain & Sanjay K. Jain. 2017. Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics. Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics 171 191 .
Xu Song, Zhuoya Wan, Tijia Chen, Yao Fu, Kejun Jiang, Xiaoli Yi, Huan Ke, Jianxia Dong, Liuqing Yang, Lin Li, Xun Sun, Tao Gong & Zhirong Zhang. (2016) Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment. Biomaterials 108, pages 44-56.
Crossref
ſucja Przysiecka, Martyna Michalska, Grzegorz Nowaczyk, Barbara Pepliſska, Teofil Jesionowski, Raphaël Schneider & Stefan Jurga. (2016) iRGD peptide as effective transporter of CuInZnxS2+x quantum dots into human cancer cells. Colloids and Surfaces B: Biointerfaces 146, pages 9-18.
Crossref
Gang SHEN, Ling CHENG, Li-Qiang WANG, Li-Hong ZHANG, Bao-De SHEN, Wei-Bo LIAO, Juan-Juan LI, Juan ZHENG, Rong XU & Hai-Long YUAN. (2016) Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability. Chinese Journal of Natural Medicines 14:10, pages 757-768.
Crossref
Daniela Arosio & Cesare Casagrande. (2016) Advancement in integrin facilitated drug delivery. Advanced Drug Delivery Reviews 97, pages 111-143.
Crossref
Binlong Chen, Zhaoyang Wang, Jing Sun, Qin Song, Bing He, Hua Zhang, Xueqing Wang, Wenbing Dai & Qiang Zhang. (2016) A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts. Nanomedicine: Nanotechnology, Biology and Medicine 12:1, pages 131-141.
Crossref
Vítor M. Gaspar, André F. Moreira, Duarte de Melo-Diogo, Elisabete C. Costa, João A. Queiroz, Fani Sousa, Chantal Pichon & Ilídio J. Correia. 2016. Nanobiomaterials in Medical Imaging. Nanobiomaterials in Medical Imaging 163 207 .
Qing Zhang, Yang Zhang, Ke Li, Haiyu Wang, Huizhong Li & Junnian Zheng. (2015) A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD. PLOS ONE 10:6, pages e0129865.
Crossref
Grazia Graziani & Pedro M. Lacal. (2015) Neuropilin-1 as Therapeutic Target for Malignant Melanoma. Frontiers in Oncology 5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.